Health and Fitness Health and Fitness
Tue, November 29, 2011
[ Tue, Nov 29th 2011 ] - Market Wire
Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
[ Tue, Nov 29th 2011 ] - Market Wire
Natural Alternatives International, Inc. Announce .. Beta-Alanine Patent Protecting CarnoSyn Products
[ Tue, Nov 29th 2011 ] - Market Wire
Soliris (eculizumab) riceve l'autorizzazione alla .. a per il trattamento dei pazienti affetti da sind
[ Tue, Nov 29th 2011 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 6th A .. ular, Aesthetics & Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Extraordinary general meeting of shareholders of Basilea Pharmaceutica Ltd.
[ Tue, Nov 29th 2011 ] - Market Wire
TheraBiogen, Inc. Launches National Radio Ad Campaign
[ Tue, Nov 29th 2011 ] - Market Wire
Medicure Reports First Quarter 2012 Financial Results
[ Tue, Nov 29th 2011 ] - Market Wire
Gilead krijgt Europese vergunning voor het in de .. een nieuw, compleet eenmaal daags enkel-tablet r
[ Tue, Nov 29th 2011 ] - Market Wire
Vergunning verleend voor het in de handel brengen .. Europa ter behandeling van patinten met atypisch
[ Tue, Nov 29th 2011 ] - Market Wire
Soliris (eculizumab) obtiene autorizacin para com .. l tratamiento de pacientes con sndrome urmico hem
[ Tue, Nov 29th 2011 ] - Market Wire
Humana Announces Agreement to Acquire SeniorBridge
[ Tue, Nov 29th 2011 ] - Market Wire
Gilead obtiene autorizacin de comercializacin en .. vo rgimen de nica pastilla, una vez al da para la
[ Tue, Nov 29th 2011 ] - Market Wire
Cubist Pharmaceuticals to Present at December 2011 Investor Conferences
[ Tue, Nov 29th 2011 ] - Market Wire
Gilead erhlt europische Marktzulassung fr Evipler .. erabreichtes Kombiprparat in Form einer Einzeltab
[ Tue, Nov 29th 2011 ] - Market Wire
IsoRay, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
[ Tue, Nov 29th 2011 ] - Market Wire
PhotoMedex Helps Psoriasis Patients Ease Winter Skin Care Woes
[ Tue, Nov 29th 2011 ] - Market Wire
DiaMedica Announces Formation of Development Advi .. Group for Its DM-199 and DM-204 Diabetes Products
[ Tue, Nov 29th 2011 ] - Market Wire
BioElectronics Appoints a Director of Clinical Research
[ Tue, Nov 29th 2011 ] - Market Wire
Direction of Market Influences - Report Highlight .. hnologies Corp. and Thermo Fisher Scientific Inc.
[ Tue, Nov 29th 2011 ] - Market Wire
Watson's Generic Yaz(R) Receives FDA Approval
[ Tue, Nov 29th 2011 ] - Market Wire
CryoLife to Present at 6th Annual Canaccord Genui .. ular, Aesthetics & Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
Health Net Hosts 20th Annual Celebration of Children
[ Tue, Nov 29th 2011 ] - Market Wire
Dendreon and Human Genome Sciences - Ready to Turn Fortunes Around
[ Tue, Nov 29th 2011 ] - Market Wire
WeedMaps Announces Acquisition of Domain Name Marijuana.com
[ Tue, Nov 29th 2011 ] - Market Wire
EnteroMedics to Present at the Canaccord Genuity .. ar, Aesthetics and Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
FDA Accepts ELIQUIS (apixaban) New Drug Applicati .. ion of Stroke and Systemic Embolism in Patients w
[ Tue, Nov 29th 2011 ] - Market Wire
Marina Biotech and Debiopharm SA Achieve Key Pre-Clinical Milestone in Bladder Cancer Program
[ Tue, Nov 29th 2011 ] - Market Wire
Cytokinetics Announces Opening of Third Phase II .. 57 in Patients With Amyotrophic Lateral Sclerosis
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Announces Resignation of Its President &;; CEO
[ Tue, Nov 29th 2011 ] - Market Wire
Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference

Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference


Published on 2011-11-29 04:15:45 - Market Wire
  Print publication without navigation


RALEIGH, N.C.--([ ])--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at The Oppenheimer 22nd Annual Healthcare Conference in New York, NY on Tuesday, December 13, 2011 at 1:35 p.m. ET.

Interested parties can access a live audio web cast of the presentation at [ http://www.salix.com ]. A replay of the presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salixas strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Companyas gastroenterology specialty sales and marketing team.

Salix trades on the NASDAQ Global Select Market under the ticker symbol aSLXPa.

For more information, please visit our Website at [ www.salix.com ] or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook ([ www.facebook.com/SalixPharma ]). Information on our web site is not incorporated in our SEC filings.

Contributing Sources